BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 24, 2016
View Archived Issues
Profounda announces launch of Impavido in the U.S.
Read More
Thomson Reuters Drug News Publication Holidays
Read More
Regen BioPharma submits IND application for tCellVax to the FDA
Read More
Bayer Schering Pharma patents AKR1C3 inhibitors
Read More
Novartis discloses Raf kinase C and B inhibitors
Read More
Chiesi Farmaceutici develops PI3K inhibitors
Read More
GlaxoSmithKline divulges Ret inhibitors
Read More
Initiation of phase II study evaluating AGS-003 for the treatment of NSCLC
Read More
Boehringer Ingelheim Pharma reports DPP-I inhibitors
Read More
BioLineRx starts phase II trial for BL-8040 as novel stem cell mobilization treatment
Read More
Novel targets and animal models presented at EAU
Read More
First subject dosed in phase Ia healthy volunteer study evaluating SNS-062
Read More
Host cell protein complex identified as a potential HBV therapy target
Read More
Bio-Path and UT Southwestern enter SLE research agreement
Read More
Bristol-Myers Squibb to acquire Padlock Therapeutics
Read More
Ultragenyx and Saint Louis University to develop muscular dystrophy treatments
Read More
RMC-035, a novel drug candidate for treating pre-eclampsia
Read More
Novel liver-directed glucokinase activator discovered at Advinus
Read More
OncoTherapy confirms positive phase I results for OTSA-101
Read More
ITM Isotopen Technologien Munchen and Scil Proteins partner on targeted radio conjugates
Read More
Agilis Biotherapeutics and T-TOP Clinical Research to collaborate on AADC deficiency gene therapy
Read More
FDA approves Cinqair injection
Read More
Vernalis presents Chk1 inhibitor VER-250840
Read More
Roche submits Elecsys BRAHMS PCT sepsis assay to the FDA
Read More
Swedish Orphan Biovitrum becomes marketing authorisation holder of efmoroctocog alfa in the E.U.
Read More
Eisai withdraws NDA for ultra-high dose mecobalamin in Japan
Read More
Phase IIb trial of NTCELL for Parkinson's disease underway in New Zealand
Read More